Aflibercept (eylea) for age-related macular degeneration
- PMID: 22354219
Aflibercept (eylea) for age-related macular degeneration
Similar articles
-
Aflibercept for age-related macular degeneration: a game-changer or quiet addition?Am J Ophthalmol. 2012 Aug;154(2):222-6. doi: 10.1016/j.ajo.2012.04.020. Am J Ophthalmol. 2012. PMID: 22813448 Review.
-
Intravitreal aflibercept for neovascular age-related macular degeneration.Immunotherapy. 2013 Feb;5(2):121-30. doi: 10.2217/imt.12.158. Immunotherapy. 2013. PMID: 23413903
-
Aflibercept-related sterile inflammation.Ophthalmology. 2013 May;120(5):1100-101.e1-5. doi: 10.1016/j.ophtha.2012.11.018. Ophthalmology. 2013. PMID: 23642742 No abstract available.
-
Ziv-aflibercept (Zaltrap) for metastatic colorectal cancer.Med Lett Drugs Ther. 2013 Apr 29;55(1415):e36. Med Lett Drugs Ther. 2013. PMID: 23836346 Review. No abstract available.
-
Regeneron focuses on age-related macular degeneration.Chem Biol. 2008 Apr;15(4):303-4. doi: 10.1016/j.chembiol.2008.04.002. Chem Biol. 2008. PMID: 18420133 No abstract available.
Cited by
-
Four-Year Outcome of Aflibercept Treatment-Naïve Patients for Neovascular Age-Related Macular Degeneration: Evidence from a Clinical Setting.J Ophthalmol. 2020 Mar 25;2020:7465270. doi: 10.1155/2020/7465270. eCollection 2020. J Ophthalmol. 2020. PMID: 32318284 Free PMC article.
-
Comparative effectiveness of aflibercept for the treatment of patients with neovascular age-related macular degeneration.Clin Ophthalmol. 2013;7:495-501. doi: 10.2147/OPTH.S29974. Epub 2013 Mar 8. Clin Ophthalmol. 2013. PMID: 23503202 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical